Clinical Trials · NCT04524832
Research Study Comparing New Tablets of Semaglutide in New Doses, in Healthy People
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 290
- Start date
- Sep 2020
- Locations
- 1 site, Germany
- Primary endpoint
- Area under the semaglutide plasma concentration - time curve during a dosing interval at steady state (AUC0-24h,sema,SS)